The breast imaging manager was in the middle of a busy morning when her phone rang. She recognized the number. It was one of their largest referring physicians.
She picked up expecting a question about a report, a scheduling issue, a patient concern. "Good morning, Doctor. How can I help you?"
There was a brief pause. "I just wanted to thank you," he said.
Several months earlier, he had referred a patient to the facility for a mammogram. The exam was completed. The report was finalized. The patient received her lay letter explaining that she needed to return for additional follow-up. But the report never made it back to the referring physician's office. No one realized it at first.
No definitive explanation was ever established for why the report didn't arrive. That ambiguity is itself instructive. In a 2024 survey of 2,088 family physicians published in JAMA Network Open, 32% said complete patient records from outside organizations were not available to them "to a great extent," and 23% said key information was missing within the record. Only 8% said information from a different EHR vendor was very easy to use. The report's failure to arrive was not a bizarre edge case. It was a documented, recurring feature of how health information moves (or doesn't) between organizations.
Thirty days passed. Then sixty. Then ninety. During that time, the facility's follow-up protocol continued to move forward. The patient received reminders. Outreach was made. Still, nothing happened.
Patients who skip recommended follow-up after an imaging procedure are classified as lost to follow-up, and the reasons are rarely simple. Language barriers, financial concerns, fear of a diagnosis, anxiety about procedures, scheduling difficulties, transportation, competing life responsibilities: any one of these, or some combination of them, can stand between a patient and a recommended next step. The outreach went out. She didn't come back. The why may never be known.
At the 90-day mark, the Mammologix overdue protocol was triggered. A formal Overdue Inquiry was faxed to the referring physician. It was not a generic reminder. It contained the patient's basic demographics, the procedure performed, the imaging assessment, the procedure recommended, the interpreting physician, the date of service, the follow-up-by date, a direct request for follow-up information, and the regulatory basis for the inquiry under FDA MQSA requirements. A letter also went to the patient.
This time, the connection was made. The physician received the report and the inquiry together. The patient received the overdue notice. The patient called the physician. The recommended follow-up was scheduled.
That follow-up led to a suspicious finding. A biopsy was performed. The patient was diagnosed and moved into a treatment plan.
"If that overdue notice had not come through," the physician told the manager, "we would not have known. Thank you for having this process in place."
After the call ended, the manager contacted Mammologix. She wanted to say thank you, too, not because something unusual had happened, but because the system had worked exactly the way it was supposed to work.
That is what the 30-60-90 day follow-up program is. Not a reminder system. A safety net. Another layer of protection between a patient and a missed diagnosis, for the moments when reports are not received, patients do not respond, offices are busy, and communication breaks down in ways no one can fully explain or prevent.
Most days, this work happens quietly in the background. But sometimes a physician picks up the phone and says thank you. And in that moment, everyone is reminded why the process matters.